Author: Jarvis Chris A. Heard Charles M. McGuigan Chris
Publisher: Informa Healthcare
ISSN: 1061-186X
Source: Journal of Drug Targeting, Vol.11, Iss.7, 2003-08, pp. : 433-441
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Varicella zoster virus (VZV) is responsible for causing chickenpox and shingles infections, the latter of which can lead to long-term post-herpetic neuralgia (PHN), the most common complication of VZV infections. A class of anti-VZV nucleoside analogues has been synthesised that shows up to 30,000 times the potency of aciclovir
Related content
Varicella zoster virus latency
By Eshleman Emily Shahzad Aamir Cohrs Randall J
Future Virology, Vol. 6, Iss. 3, 2011-03 ,pp. :
Adalimumab: Varicella zoster virus encephalitis: case report
Reactions Weekly, Vol. 1, Iss. 1331, 2010-01 ,pp. :
Emerging drugs for varicella-zoster virus infections
By Andrei Graciela Snoeck Robert
Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. :